Jeff Vacirca

Jeff Vacirca, MD, FACP, is the CEO and Chairman of the Board of New York Cancer & Blood Specialists (NYCBS), a position assumed in 2008. They have significantly transformed NYCBS into a leading oncology practice serving nearly one million patients annually across multiple locations. Additionally, Jeff is involved with various organizations, including serving on the boards of Spectrum Pharmaceuticals, OneOncology, and the American Red Cross of Greater New York, focusing on legislative advocacy for cancer care access. Jeff co-founded Odonate Therapeutics in 2016 and has held key roles in medical leadership and advisory capacities across numerous healthcare entities. Their commitment to community oncology is further exemplified by founding the New York Cancer Foundation, which provides financial assistance to cancer patients.